<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04223401</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT04223401</nct_id>
  </id_info>
  <brief_title>Prehabilitation for Gastrectomy</brief_title>
  <acronym>PREFOG</acronym>
  <official_title>Personalized Trimodal Prehabilitation for Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Lithuania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vilnius University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vilnius University Hospital Santaros Klinikos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Institute, Lithuania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prehabilitation has been demonstrated to be an effective strategy to improve outcomes in&#xD;
      patients undergoing some of the abdominal operations. It may increase the physical capacity&#xD;
      of the patient, improve postoperative quality of life and even decrease the postoperative&#xD;
      morbidity. Currently, the most effective strategy seems to be a trimodal prehabilitation&#xD;
      which includes: 1) Nutritional support 2) Psychological support and 3) Physical training.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will investigate personalized trimodal prehabilitation for patients undergoing&#xD;
      gastrectomy for gastric cancer.&#xD;
&#xD;
      Prehabilitation group:&#xD;
&#xD;
      Patients will undergo 6 Minutes Walking Test (6-MWT), spiroergometry (VO2 max; AT), a grip&#xD;
      strength test, a timed Up &amp; Go (TUG) test, 10 m sprint test and sit to stand test before and&#xD;
      after prehabilitation. The trimodal intervention will involve:&#xD;
&#xD;
        1. Nutritional intervention: The dietetic physician will perform physical examination and&#xD;
           evaluation of the nutritional status to provide individualized care to each patient.&#xD;
           Patients will receive personalized recommendations for the prevention or correction of&#xD;
           malnutrition.&#xD;
&#xD;
        2. Psychological intervention: Patients will undergo consultation by specialized&#xD;
           onco-psychologist. The anxiety and depression level will be evaluated by HAD score and&#xD;
           patients will be trained to perform techniques, such as relaxation to reduce and manage&#xD;
           anxiety on at home basis.&#xD;
&#xD;
           The psychologist also will enhance patients' motivation to comply with the exercise and&#xD;
           nutritional aspects of the intervention.&#xD;
&#xD;
        3. Exercise intervention: Patients will be consulted by PM&amp;R physicians and&#xD;
           physiotherapists and personalized exercise plans will be developed according to the&#xD;
           results of 6MWT, AT and VO2peak. Exercises will focus on skeletal muscles and&#xD;
           cardiopulmonary function training and the exercises feasible at home basis will be&#xD;
           selected. All patients will undergo three supervised training sessions to learn the&#xD;
           correct exercise techniques.&#xD;
&#xD;
      All patients will be routinely contacted to ensure compliance with prehabilitation program.&#xD;
&#xD;
      Patients scheduled for surgery first by multidisciplinary tumor board will undergo 4 weeks&#xD;
      prehabilitation program, while patients scheduled for perioperative chemotherapy will undergo&#xD;
      prehabilitation while neoadjuvant treatment will be administered.&#xD;
&#xD;
      Control group:&#xD;
&#xD;
      Patients will also undergo 6 Minutes Walking Test (6-MWT), spiroergometry (VO2 max; AT), a&#xD;
      grip strength test, a timed Up &amp; Go (TUG) test, 10 m sprint test and sit to stand test before&#xD;
      surgery or before and after neoadjuvant chemotherapy. Patients will not undergo&#xD;
      prehabilitation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative morbidity rate by Clavien-Dindo</measure>
    <time_frame>At 90 days postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical status by Spiroergometry</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical status by International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative mortality rate</measure>
    <time_frame>At 30 and 90 days postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status by albumin level</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life by EORTC questionnaires</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients reaching the complete oncological treatment fixed in a multidisciplinary tumour board (including preoperative chemotherapy, surgery and postoperative chemotherapy)</measure>
    <time_frame>12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical status by grip strength test</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical status by 6 minutes walk test</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical status by the sit to stand test</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical status by the timed up&amp;go test</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological status by Hospital Anxiety and Depression Scale (HADS).</measure>
    <time_frame>Baseline, pre-surgery, 3, 6 and 12 months after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Prehabilitation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the experimental group will undergo prehabilitation before the elective surgery for gastric cancer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in the control group will not undergo prehabilitation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prehabilitation</intervention_name>
    <description>Patients will undergo 6 Minutes Walking Test (6-MWT), spiroergometry (VO2 max; AT), a grip strength test, a timed Up &amp; Go (TUG) test, 10 m sprint test and sit to stand test before and after prehabilitation. The trimodal intervention will involve:&#xD;
Nutritional intervention&#xD;
Psychological intervention&#xD;
Exercise intervention</description>
    <arm_group_label>Prehabilitation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient â‰¥ 18 years old&#xD;
&#xD;
          -  Patient agrees to participate in a clinical study&#xD;
&#xD;
          -  Patient requires surgical treatment for gastric cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient requiring surgical treatment for recurrent gastric cancer&#xD;
&#xD;
          -  Patient condition not allowing to postpone surgery for at least 4 weeks&#xD;
&#xD;
          -  Patients physical or mental condition which will not allow the patient to participate&#xD;
             in prehabilitation program&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kestutis Strupas, MD PhD Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vilnius University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Augustinas Bausys, MD</last_name>
    <phone>+370 6 23 63865</phone>
    <email>abpelikanas@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Cancer Institute</name>
      <address>
        <city>Vilnius</city>
        <zip>09239</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Augustinas Bausys, MD</last_name>
      <email>abpelikanas@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vilnius University hospital Santaros klinikos</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kestutis Strupas, MD PhD Prof.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Lithuania</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 6, 2020</study_first_submitted>
  <study_first_submitted_qc>January 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2020</study_first_posted>
  <last_update_submitted>March 7, 2021</last_update_submitted>
  <last_update_submitted_qc>March 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

